Education
About Us
Working with TipRanks
Follow Us
Novo Nordisk (DE:NOV)
XETRA:NOV
Total Valuation
Novo Nordisk has a market cap or net worth of kr253.78B. The enterprise value is ―.
Market Capkr253.78B
Enterprise Value―
Share Statistics
Novo Nordisk has 3,390,128,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,390,128,000
Owned by Insiders5.28%
Owned by Institutions<0.01%
Financial Efficiency
Novo Nordisk’s return on equity (ROE) is 0.70 and return on invested capital (ROIC) is 38.99%.
Return on Equity (ROE)0.70
Return on Assets (ROA)0.22
Return on Invested Capital (ROIC)38.99%
Return on Capital Employed (ROCE)0.52
Revenue Per Employee3.75M
Profits Per Employee1.30M
Employee Count77,406
Asset Turnover0.62
Inventory Turnover1.09
Valuation Ratios
The current PE Ratio of Novo Nordisk is 27.53. Novo Nordisk’s PEG ratio is 3.63.
PE Ratio27.53
PS Ratio0.00
PB Ratio17.05
Price to Fair Value19.38
Price to FCF37.87
Price to Operating Cash Flow20.23
PEG Ratio3.63
Income Statement
In the last 12 months, Novo Nordisk had revenue of 290.40B and earned 100.99B in profits. Earnings per share was 22.67.
Revenue290.40B
Gross Profit245.88B
Operating Income128.34B
Pretax Income127.19B
Net Income100.99B
EBITDA137.38B
Earnings Per Share (EPS)22.67
Cash Flow
In the last 12 months, operating cash flow was 120.97B and capital expenditures -50.92B, giving a free cash flow of 70.04B billion.
Operating Cash Flow120.97B
Free Cash Flow70.04B
Free Cash Flow per Share20.66
Dividends & Yields
Novo Nordisk pays an annual dividend of €1.059, resulting in a dividend yield of 2.61%
Dividend Per Share€1.059
Dividend Yield2.61%
Payout Ratio33.65%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.48
52-Week Price Change-49.92%
50-Day Moving Average61.75
200-Day Moving Average89.35
Relative Strength Index (RSI)54.16
Average Volume (3m)273.64K
Important Dates
Novo Nordisk upcoming earnings date is Aug 6, 2025, TBA Not Confirmed.
Last Earnings DateMay 7, 2025
Next Earnings DateAug 6, 2025
Ex-Dividend DateMar 28, 2025
Financial Position
Novo Nordisk as a current ratio of 0.74, with Debt / Equity ratio of 71.64%
Current Ratio0.74
Quick Ratio0.55
Debt to Market Cap0.03
Net Debt to EBITDA0.63
Interest Coverage Ratio78.26
Taxes
In the past 12 months, Novo Nordisk has paid 26.20B in taxes.
Income Tax26.20B
Effective Tax Rate0.21
Enterprise Valuation
Novo Nordisk EV to EBITDA ratio is 20.87, with an EV/FCF ratio of 41.16.
EV to Sales9.87
EV to EBITDA20.87
EV to Free Cash Flow41.16
EV to Operating Cash Flow23.70
Balance Sheet
Novo Nordisk has kr26.31B in cash and marketable securities with kr102.79B in debt, giving a net cash position of kr76.48B billion.
Cash & Marketable Securitieskr26.31B
Total Debtkr102.79B
Net Cashkr76.48B
Net Cash Per Sharekr22.56
Tangible Book Value Per Sharekr7.27
Margins
Gross margin is 84.67%, with operating margin of 44.19%, and net profit margin of 34.78%.
Gross Margin84.67%
Operating Margin44.19%
Pretax Margin43.80%
Net Profit Margin34.78%
EBITDA Margin47.31%
EBIT Margin44.36%
Analyst Forecast
The average price target for Novo Nordisk is kr88.97, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Targetkr88.97
Price Target Upside50.88% Upside
Analyst ConsensusModerate Buy
Analyst Count14
Revenue Growth Forecast―
EPS Growth Forecast―